Oldroyd, A. G. S. et al. British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy. Rheumatology 61, 1760–1768 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Chinoy, H. & Lilleker, J. B. Pitfalls in the diagnosis of myositis. Best. Pract. Res. Clin. Rheumatol. 34, 101486 (2020).

Article  PubMed  Google Scholar 

Lundberg, I. E. et al. Idiopathic inflammatory myopathies. Nat. Rev. Dis. Prim. 7, 86 (2021).

Article  PubMed  Google Scholar 

Barsotti, S. & Lundberg, I. E. Myositis an evolving spectrum of disease. Immunol. Med. 41, 46–54 (2018).

Article  PubMed  Google Scholar 

Namsrai, T. et al. Diagnostic delay of myositis: an integrated systematic review. Orphanet J. Rare Dis. 17, 420 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Mammen, A. L. Which nonautoimmune myopathies are most frequently misdiagnosed as myositis? Curr. Opin. Rheumatol. 29, 618–622 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bernatsky, S., Linehan, T. & Hanly, J. G. The accuracy of administrative data diagnoses of systemic autoimmune rheumatic diseases. J. Rheumatol. 38, 1612–1616 (2011).

Article  PubMed  Google Scholar 

Tanno, L. K. et al. Global implementation of the world health organization’s International Classification of Diseases (ICD)-11: the allergic and hypersensitivity conditions model. Allergy 75, 2206–2218 (2020).

Article  PubMed  Google Scholar 

Bohan, A. & Peter, J. B. Polymyositis and dermatomyositis (first of two parts). N. Engl. J. Med. 292, 344–347 (1975).

Article  CAS  PubMed  Google Scholar 

Bohan, A. & Peter, J. B. Polymyositis and dermatomyositis (second of two parts). N. Engl. J. Med. 292, 403–407 (1975).

Article  CAS  PubMed  Google Scholar 

Carpenter, S., Karpati, G., Heller, I. & Eisen, A. Inclusion body myositis: a distinct variety of idiopathic inflammatory myopathy. Neurology 28, 8–17 (1978).

Article  CAS  PubMed  Google Scholar 

Griggs, R. C. et al. Inclusion body myositis and myopathies. Ann. Neurol. 38, 705–713 (1995).

Article  CAS  PubMed  Google Scholar 

Hoogendijk, J. E. et al. 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands. Neuromuscul. Disord. 14, 337–345 (2004).

Article  PubMed  Google Scholar 

Day, J., Otto, S., Cash, K. & Limaye, V. Clinical and histological features of immune-mediated necrotising myopathy: a multi-centre South Australian cohort study. Neuromuscul. Disord. 30, 186–199 (2020).

Article  PubMed  Google Scholar 

Allenbach, Y., Benveniste, O., Stenzel, W. & Boyer, O. Immune-mediated necrotizing myopathy: clinical features and pathogenesis. Nat. Rev. Rheumatol. 16, 689–701 (2020).

Article  CAS  PubMed  Google Scholar 

Allenbach, Y. et al. High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody. Brain 139, 2131–2135 (2016).

Article  PubMed  Google Scholar 

Kassardjian, C. D., Lennon, V. A., Alfugham, N. B., Mahler, M. & Milone, M. Clinical features and treatment outcomes of necrotizing autoimmune myopathy. JAMA Neurol. 72, 996–1003 (2015).

Article  PubMed  Google Scholar 

Ma, X., Xu, L., Ji, S., Li, Y. & Bu, B. The clinicopathological distinction between seropositive and seronegative immune-mediated necrotizing myopathy in China. Front. Neurol. 12, 670784 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Allenbach, Y., Mammen, A. L., Benveniste, O. & Stenzel, W. & Immune-Mediated Necrotizing Myopathies Working Group. 224th ENMC International Workshop:: clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14–16 October 2016. Neuromuscul. Disord. 28, 87–99 (2018).

Article  PubMed  Google Scholar 

Bernstein, R. M. et al. Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease. Br. Med. J. 289, 151–152 (1984).

Article  CAS  Google Scholar 

Tieu, J., Lundberg, I. E. & Limaye, V. Idiopathic inflammatory myositis. Best. Pract. Res. Clin. Rheumatol. 30, 149–168 (2016).

Article  PubMed  Google Scholar 

Opinc, A. H. & Makowska, J. S. Antisynthetase syndrome — much more than just a myopathy. Semin. Arthritis Rheum. 51, 72–83 (2021).

Article  CAS  PubMed  Google Scholar 

Huang, K. & Aggarwal, R. Antisynthetase syndrome: a distinct disease spectrum. J. Scleroderma Relat. Disord. 5, 178–191 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Uruha, A. et al. Diagnostic potential of sarcoplasmic myxovirus resistance protein A expression in subsets of dermatomyositis. Neuropathol. Appl. Neurobiol. 45, 513–522 (2019).

Article  CAS  PubMed  Google Scholar 

Aouizerate, J. et al. Myofiber HLA-DR expression is a distinctive biomarker for antisynthetase-associated myopathy. Acta Neuropathol. Commun. 2, 154 (2014).

Article  PubMed  PubMed Central  Google Scholar 

Dalakas, M. C. Complement in autoimmune inflammatory myopathies, the role of myositis-associated antibodies, COVID-19 associations, and muscle amyloid deposits. Expert. Rev. Clin. Immunol. 18, 413–423 (2022).

Article  CAS  PubMed  Google Scholar 

Aguila, L. A. et al. Overlap syndromes of idiopathic inflammatory myopathies with systemic lupus erythematosus, systemic sclerosis or rheumatoid arthritis. Lupus 22, 136 (2013).

Google Scholar 

Keck, A. D., Jaeger, V. K. & Walker, U. A. Myositis in systemic sclerosis, lupus erythematosus and Sjogren’s syndrome. Aktuelle Rheumatol. 42, 310–315 (2017).

Article  Google Scholar 

Paik, J. J. Myopathy in scleroderma and in other connective tissue diseases. Curr. Opin. Rheumatol. 28, 631–635 (2016).

Article  CAS  PubMed  Google Scholar 

Leclair, V., Notarnicola, A., Vencovsky, J. & Lundberg, I. E. Polymyositis: does it really exist as a distinct clinical subset? Curr. Opin. Rheumatol. 33, 537–543 (2021).

Article  CAS  PubMed  Google Scholar 

Betteridge, Z. et al. Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients. J. Autoimmun. 101, 48–55 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hodgkinson, L. M., Wu, T. T. & Fiorentino, D. F. Dermatomyositis autoantibodies: how can we maximize utility? Ann. Transl. Med. 9, 433 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen, Z. et al. Distinct profiles of myositis-specific autoantibodies in Chinese and Japanese patients with polymyositis/dermatomyositis. Clin. Rheumatol. 34, 1627–1631 (2015).

Article  PubMed  Google Scholar 

McHugh, N. J. & Tansley, S. L. Autoantibodies in myositis. Nat. Rev. Rheumatol. 14, 290–302 (2018).

Article  CAS  PubMed  Google Scholar 

Benveniste, O. & Hilton-Jones, D. International workshop on inclusion body myositis held at the institute of myology, Paris, on 29 May 2009. Neuromuscul. Disord. 20, 414–421 (2010).

Article  PubMed  Google Scholar 

Dalakas, M. C. & Hohlfeld, R. Polymyositis and dermatomyositis. Lancet 362, 971–982 (2003).

Article  CAS  PubMed  Google Scholar 

Hilton-Jones, D. & Brady, S. Diagnostic criteria for inclusion body myositis. J. Intern. Med. 280, 52–62 (2016).

Article  CAS  PubMed  Google Scholar 

Lloyd, T. E. et al. Evaluation and construction of diagnostic criteria for inclusion body myositis. Neurology 83, 426–433 (2014).

Article  PubMed  PubMed Central  Google Scholar 

Mammen, A. L., Allenbach, Y., Stenzel, W., Benveniste, O. & ENMC 239th Workshop Study Group. 239th ENMC international workshop: classification of dermatomyositis, Amsterdam, the Netherlands, 14–16 December 2018. Neuromuscul. Disord. 30, 70–92 (2020).

Article  PubMed  Google Scholar 

Rose, M. R. & Group, E. I. W. 188th ENMC international workshop: inclusion body myositis, 2–4 December 2011, Naarden, The Netherlands. Neuromuscul. Disord. 23, 1044–1055 (2013).

Article  CAS  PubMed